Increased in vivo regeneration of cortisol in adipose tissue in human obesity and effects of the 11β-hydroxysteroid dehydrogenase type 1 inhibitor carbenoxolone

被引:164
|
作者
Sandeep, TC [1 ]
Andrew, R [1 ]
Homer, NZM [1 ]
Andrews, RC [1 ]
Smith, K [1 ]
Walker, BR [1 ]
机构
[1] Univ Edinburgh, Western Gen Hosp, Sch Mol & Clin Med, Endocrinol Unit, Edinburgh EH4 2XU, Midlothian, Scotland
关键词
D O I
10.2337/diabetes.54.3.872
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
11beta-Hydroxysteroid dehydrogenase type 1 (11HSD1) regenerates cortisol from cortisone within adipose tissue and liver. 11HSD1 inhibitors may enhance insulin sensitivity in type 2 diabetes and be most efficacious in obesity when 11HSD1 is increased in subcutaneous adipose biopsies. We examined the regeneration of cortisol in vivo in obesity, and the effects of the 11HSD1 inhibitor carbenoxolone. We compared six lean and six obese men and performed a randomized, placebo-controlled crossover study of carbenoxolone in obese men. The obese men had no difference in their whole-body rate of regenerating cortisol (measured with 9,11,12,12-[H-2(4)]cortisol tracer), but had more rapid conversion of [H-3]cortisone to [H-3]cortisol in abdominal subcutaneous adipose tissue (measured with microdialysis). During insulin infusion, adipose 11HSD1 activity fell markedly in lean but not in obese men. Carbenoxolone inhibited whole-body cortisol regeneration, but did not significantly inhibit adipose 11HSD1 and had no effects on insulin sensitivity (measured by [H-2(2)]glucose infusion with or without hyperinsulinemia). Thus, in vivo cortisol generation is increased selectively within adipose tissue in obesity, perhaps reflecting resistance to insulin-mediated downregulation of 11HSD1. However, obese men are less susceptible than lean men to the insulin-sensitizing effects of carbenoxolone. To be useful in obese patients, 11HSD1 inhibitors will need to inhibit the enzyme more effectively in adipose tissue.
引用
收藏
页码:872 / 879
页数:8
相关论文
共 50 条
  • [21] Increased expression of 11β-hydroxysteroid dehydrogenase type 1 in subcutaneous adipose tissue in HIV-associated lipodystrophy
    Sutinen, J
    Kannisto, K
    Korsheninnikova, E
    Nyman, T
    Hamsten, A
    Wake, D
    Walker, B
    Yki-Järvinen, H
    ANTIVIRAL THERAPY, 2003, 8 (04) : L8 - L8
  • [22] 11β-hydroxysteroid dehydrogenase type 1 mRNA is increased in both visceral and subcutaneous adipose tissue of obese patients
    Desbriere, Raoul
    Vuaroqueaux, Vincent
    Achard, Vincent
    Boullu-Ciocca, Sandrine
    Labuhn, Martin
    Dutour, Anne
    Grino, Michel
    OBESITY, 2006, 14 (05): : 794 - 798
  • [23] Saturated fatty acids in human visceral adipose tissue are associated with increased 11- β-hydroxysteroid-dehydrogenase type 1 expression
    Paul Petrus
    Fredrik Rosqvist
    David Edholm
    Niklas Mejhert
    Peter Arner
    Ingrid Dahlman
    Mikael Rydén
    Magnus Sundbom
    Ulf Risérus
    Lipids in Health and Disease, 14
  • [24] Saturated fatty acids in human visceral adipose tissue are associated with increased 11-β-hydroxysteroid-dehydrogenase type 1 expression
    Petrus, Paul
    Rosqvist, Fredrik
    Edholm, David
    Mejhert, Niklas
    Arner, Peter
    Dahlman, Ingrid
    Ryden, Mikael
    Sundbom, Magnus
    Riserus, Ulf
    LIPIDS IN HEALTH AND DISEASE, 2015, 14
  • [25] Inhibition of 11β-hydroxysteroid dehydrogenase type 1 in obesity
    Deborah J. Wake
    Brian R. Walker
    Endocrine, 2006, 29 : 101 - 108
  • [26] Inhibition of 11β-hydroxysteroid dehydrogenase type 1 in obesity
    Wake, DJ
    Walker, BR
    ENDOCRINE, 2006, 29 (01) : 101 - 108
  • [27] 11β-Hydroxysteroid Dehydrogenase Type 1 and 2 Enzyme Activity in Subcutaneous Adipose Tissue of Humans; Implications in Obesity and Diabetes
    Norby, Barbara
    Pattan, Vishwanath
    Dicke, Betty
    Basu, Ananda
    Rizza, Robert
    Basu, Rita
    DIABETES, 2011, 60 : A127 - A127
  • [28] 11 β-hydroxysteroid dehydrogenase type I activity in equine adipose tissue
    Farias, F. H. G.
    Johnson, P. J.
    Ganjam, V. K.
    Keisler, D. H.
    JOURNAL OF ANIMAL SCIENCE, 2007, 85 : 139 - 140
  • [29] Discovery of 11β-hydroxysteroid dehydrogenase type 1 inhibitor
    Hong, Sung Pyo
    Nam, Ky Youb
    Shin, Young June
    Kim, Kil Won
    Ahn, Soon Kil
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2015, 25 (17) : 3501 - 3506
  • [30] Is 11β-hydroxysteroid dehydrogenase type 1 a therapeutic target?: Effects of carbenoxolone in lean and obese Zucker rats
    Livingstone, DEW
    Walker, BR
    JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 2003, 305 (01): : 167 - 172